Anne Mathieu-Boué

1.6k citations
16 papers · 1.4k · h-index 10

Impact in

  • Oncology top 5%
    • Viral-associated cancers and disorders
    • Lung Cancer Research Studies
    • Polyomavirus and related diseases
    • Neutropenia and Cancer Infections
    • Pancreatic and Hepatic Oncology Research
  • Toxicology top 5%

Papers in

    • Lung Cancer Research Studies 2
    • Neutropenia and Cancer Infections 2
    • Cancer therapeutics and mechanisms 7

Anne Mathieu-Boué

16 papers receiving 1.3k citations

Peers

Anne Mathieu-Boué
Comparison fields: 5 of 67
  • Oncology 825
  • Toxicology 47
  • Pathology and Forensic Medicine 208
  • Transplantation 26
  • Molecular Biology 534
Replace Nathalie A. Brophy with:
Nathalie A. Brophy United States
Brian G. M. Durie United States
Soh Saitoh Japan
Dwayne Bracy United States
Douglas B. Johnson United States
Aurélien Gobert France
Patrick Houlihan United States
Donald R. Fleming United States
Miyuki Akutsu Japan
R. Adam France
Anne Mathieu-Boué relative to Nathalie A. Brophy United States Nathalie A. Brophy's profile →
Citations per field
00.5×2×4×6×7.8×
Nathalie A. Brophy · 1×
Citations per year

Countries citing papers authored by Anne Mathieu-Boué

Since Specialization
Citations

This map shows the geographic impact of Anne Mathieu-Boué's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Mathieu-Boué with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Mathieu-Boué more than expected).

Fields of papers citing papers by Anne Mathieu-Boué

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Mathieu-Boué. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Mathieu-Boué. The network helps show where Anne Mathieu-Boué may publish in the future.

Co-authors

The 25 scholars most cited alongside Anne Mathieu-Boué, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anne Mathieu-Boué Line = papers co-authored together Anne Mathieu-Boué links everyone, so they are left out of the graph.

All Works

16 of 16 papers shown
#Work
1 2000320
2 1995156
3
Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against human tumor xenografts: lack of cross-resistance in vivo in tumors with acquired resistance to the topoisomerase I inhibitor 9-dimethylaminomethyl-10-hydroxycamptothecin.
1993155
4
Phase I and pharmacokinetic study of the camptothecin derivative irinotecan, administered on a weekly schedule in cancer patients.
1994139
5 2010110
6 1996102
7 199397
8 199597
9 199884
10 199271
11 19955
12 19985
13 20035
14 20034
15 19882
16 20061

About Anne Mathieu-Boué

Anne Mathieu-Boué is a scholar working on Oncology, Molecular Biology, Genetics, Organic Chemistry and Pediatrics, Perinatology and Child Health, having authored 16 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (7 papers), Lung Cancer Research Studies (2 papers), Neutropenia and Cancer Infections (2 papers), Childhood Cancer Survivors' Quality of Life (2 papers), Sarcoma Diagnosis and Treatment (1 paper), interferon and immune responses (1 paper), Antibiotics Pharmacokinetics and Efficacy (1 paper) and Synthetic Organic Chemistry Methods (1 paper). The work is most often cited by research in Oncology (825 citations), Toxicology (47 citations), Pathology and Forensic Medicine (208 citations), Transplantation (26 citations) and Molecular Biology (534 citations). Anne Mathieu-Boué has collaborated with scholars based in France, Belgium and Netherlands. Frequent co-authors include Guy G. Chabot, Albert Faye, Alain Gouyette, Gilles Catimel, Marcel De Forni, Roland Bugat, Janet A. Houghton, Pamela J. Cheshire, Peter John Houghton and Jean‐Pierre Armand. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Anti-Cancer Drugs, Clinical Cancer Research and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact